Editas Medicine, Inc. is a company in the U.S. stock market and it is a holding in 43 U.S.-traded ETFs. EDIT has around 9.0M shares in the U.S. ETF market. The largest ETF holder of EDIT is the ARK Innovation ETF (ARKK), with approximately 2.63M shares. Investors may also find of interest that the ETF with the largest allocation to EDIT stock is ARK Genomic Revolution ETF (ARKG), with a portfolio weight of 6.16%. On average, U.S. ETFs allocate 0.41% of EDIT to their portfolios.
Additionally, EDIT is a favorite stock for Vanilla and Growth ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with EDIT as a holding is the ARK Genomic Revolution ETF (ARKG), with a return of 12.44%.